(Q62110137)

English

Amifostine With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome

clinical trial

In more languages
default values for all languages
No label defined

No description defined

Statements

Phase II Multicenter Study of Amifostine in Patients With Myelodysplastic Syndromes at Relatively Low Risk of Developing Acute Leukemia (English)
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
0 references
August 1998
0 references
50
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit